Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions

Serena Lattante, Isabelle Le Ber, Daniela Galimberti, Maria Serpente, Sophie Rivaud-Péchoux, Agnès Camuzat, Fabienne Clot, Chiara Fenoglio, Elio Scarpini, Alexis Brice, Edor Kabashi, Sophie Auriacombe, Alexis Brice, Frédéric Blanc, Mira Didic, Bruno Dubois, Charles Duyckaerts, Marie Odile Habert, Véronique Golfier, Eric GuedjDidier Hannequin, Lucette Lacomblez, Isabelle Le Ber, Richard Levy, Vincent Meininger, Bernard François Michel, Florence Pasquier, Catherine Thomas-Anterion, Michèle Puel, François Salachas, François Sellal, Martine Vercelletto, Patrice Verpillat

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

TMEM106B was identified as a risk factor for frontotemporal lobar degeneration (FTD) with TAR DNA-binding protein 43kDa inclusions. It has been reported that variants in this gene are genetic modifiers of the disease and that this association is stronger in patients carrying a GRN mutation or a pathogenic expansion in chromosome 9 open reading frame 72 (C9orf72) gene. Here, we investigated the contribution of TMEM106B polymorphisms in cohorts of FTD and FTD with amyotrophic lateral sclerosis patients from France and Italy. Patients carrying the C9orf72 expansion (n= 145) and patients with GRN mutations (n= 76) were compared with a group of FTD patients (n= 384) negative for mutations and to a group of healthy controls (n= 552). In our cohorts, the presence of the C9orf72 expansion did not correlate with TMEM106B genotypes but the association was very strong in individuals with pathogenic GRN mutations (p= 9.54× 10-6). Our data suggest that TMEM106B genotypes differ in FTD patient cohorts and strengthen the protective role of TMEM106B in GRN carriers. Further studies are needed to determine whether TMEM106B polymorphisms are associated with other genetic causes for FTD, including C9orf72 repeat expansions.

Original languageEnglish
Pages (from-to)2658.e1-2658.e5
JournalNeurobiology of Aging
Volume35
Issue number11
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Frontotemporal Lobar Degeneration
Chromosomes, Human, Pair 9
Mutation
Open Reading Frames
Genotype
Modifier Genes
Inborn Genetic Diseases
Amyotrophic Lateral Sclerosis
DNA-Binding Proteins
Italy
France
Control Groups
Genes

Keywords

  • C9orf72
  • FTD
  • FTD-ALS
  • GRN
  • Rs1990622
  • Rs3173615
  • TMEM106B

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Ageing
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions. / Lattante, Serena; Le Ber, Isabelle; Galimberti, Daniela; Serpente, Maria; Rivaud-Péchoux, Sophie; Camuzat, Agnès; Clot, Fabienne; Fenoglio, Chiara; Scarpini, Elio; Brice, Alexis; Kabashi, Edor; Auriacombe, Sophie; Brice, Alexis; Blanc, Frédéric; Didic, Mira; Dubois, Bruno; Duyckaerts, Charles; Habert, Marie Odile; Golfier, Véronique; Guedj, Eric; Hannequin, Didier; Lacomblez, Lucette; Ber, Isabelle Le; Levy, Richard; Meininger, Vincent; Michel, Bernard François; Pasquier, Florence; Thomas-Anterion, Catherine; Puel, Michèle; Salachas, François; Sellal, François; Vercelletto, Martine; Verpillat, Patrice.

In: Neurobiology of Aging, Vol. 35, No. 11, 01.11.2014, p. 2658.e1-2658.e5.

Research output: Contribution to journalArticle

Lattante, S, Le Ber, I, Galimberti, D, Serpente, M, Rivaud-Péchoux, S, Camuzat, A, Clot, F, Fenoglio, C, Scarpini, E, Brice, A, Kabashi, E, Auriacombe, S, Brice, A, Blanc, F, Didic, M, Dubois, B, Duyckaerts, C, Habert, MO, Golfier, V, Guedj, E, Hannequin, D, Lacomblez, L, Ber, IL, Levy, R, Meininger, V, Michel, BF, Pasquier, F, Thomas-Anterion, C, Puel, M, Salachas, F, Sellal, F, Vercelletto, M & Verpillat, P 2014, 'Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions', Neurobiology of Aging, vol. 35, no. 11, pp. 2658.e1-2658.e5. https://doi.org/10.1016/j.neurobiolaging.2014.06.023
Lattante, Serena ; Le Ber, Isabelle ; Galimberti, Daniela ; Serpente, Maria ; Rivaud-Péchoux, Sophie ; Camuzat, Agnès ; Clot, Fabienne ; Fenoglio, Chiara ; Scarpini, Elio ; Brice, Alexis ; Kabashi, Edor ; Auriacombe, Sophie ; Brice, Alexis ; Blanc, Frédéric ; Didic, Mira ; Dubois, Bruno ; Duyckaerts, Charles ; Habert, Marie Odile ; Golfier, Véronique ; Guedj, Eric ; Hannequin, Didier ; Lacomblez, Lucette ; Ber, Isabelle Le ; Levy, Richard ; Meininger, Vincent ; Michel, Bernard François ; Pasquier, Florence ; Thomas-Anterion, Catherine ; Puel, Michèle ; Salachas, François ; Sellal, François ; Vercelletto, Martine ; Verpillat, Patrice. / Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 11. pp. 2658.e1-2658.e5.
@article{eb68203a52894c6db7ee7c65798ee26b,
title = "Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions",
abstract = "TMEM106B was identified as a risk factor for frontotemporal lobar degeneration (FTD) with TAR DNA-binding protein 43kDa inclusions. It has been reported that variants in this gene are genetic modifiers of the disease and that this association is stronger in patients carrying a GRN mutation or a pathogenic expansion in chromosome 9 open reading frame 72 (C9orf72) gene. Here, we investigated the contribution of TMEM106B polymorphisms in cohorts of FTD and FTD with amyotrophic lateral sclerosis patients from France and Italy. Patients carrying the C9orf72 expansion (n= 145) and patients with GRN mutations (n= 76) were compared with a group of FTD patients (n= 384) negative for mutations and to a group of healthy controls (n= 552). In our cohorts, the presence of the C9orf72 expansion did not correlate with TMEM106B genotypes but the association was very strong in individuals with pathogenic GRN mutations (p= 9.54× 10-6). Our data suggest that TMEM106B genotypes differ in FTD patient cohorts and strengthen the protective role of TMEM106B in GRN carriers. Further studies are needed to determine whether TMEM106B polymorphisms are associated with other genetic causes for FTD, including C9orf72 repeat expansions.",
keywords = "C9orf72, FTD, FTD-ALS, GRN, Rs1990622, Rs3173615, TMEM106B",
author = "Serena Lattante and {Le Ber}, Isabelle and Daniela Galimberti and Maria Serpente and Sophie Rivaud-P{\'e}choux and Agn{\`e}s Camuzat and Fabienne Clot and Chiara Fenoglio and Elio Scarpini and Alexis Brice and Edor Kabashi and Sophie Auriacombe and Alexis Brice and Fr{\'e}d{\'e}ric Blanc and Mira Didic and Bruno Dubois and Charles Duyckaerts and Habert, {Marie Odile} and V{\'e}ronique Golfier and Eric Guedj and Didier Hannequin and Lucette Lacomblez and Ber, {Isabelle Le} and Richard Levy and Vincent Meininger and Michel, {Bernard Fran{\cc}ois} and Florence Pasquier and Catherine Thomas-Anterion and Mich{\`e}le Puel and Fran{\cc}ois Salachas and Fran{\cc}ois Sellal and Martine Vercelletto and Patrice Verpillat",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.neurobiolaging.2014.06.023",
language = "English",
volume = "35",
pages = "2658.e1--2658.e5",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations andC9orf72 repeat expansions

AU - Lattante, Serena

AU - Le Ber, Isabelle

AU - Galimberti, Daniela

AU - Serpente, Maria

AU - Rivaud-Péchoux, Sophie

AU - Camuzat, Agnès

AU - Clot, Fabienne

AU - Fenoglio, Chiara

AU - Scarpini, Elio

AU - Brice, Alexis

AU - Kabashi, Edor

AU - Auriacombe, Sophie

AU - Brice, Alexis

AU - Blanc, Frédéric

AU - Didic, Mira

AU - Dubois, Bruno

AU - Duyckaerts, Charles

AU - Habert, Marie Odile

AU - Golfier, Véronique

AU - Guedj, Eric

AU - Hannequin, Didier

AU - Lacomblez, Lucette

AU - Ber, Isabelle Le

AU - Levy, Richard

AU - Meininger, Vincent

AU - Michel, Bernard François

AU - Pasquier, Florence

AU - Thomas-Anterion, Catherine

AU - Puel, Michèle

AU - Salachas, François

AU - Sellal, François

AU - Vercelletto, Martine

AU - Verpillat, Patrice

PY - 2014/11/1

Y1 - 2014/11/1

N2 - TMEM106B was identified as a risk factor for frontotemporal lobar degeneration (FTD) with TAR DNA-binding protein 43kDa inclusions. It has been reported that variants in this gene are genetic modifiers of the disease and that this association is stronger in patients carrying a GRN mutation or a pathogenic expansion in chromosome 9 open reading frame 72 (C9orf72) gene. Here, we investigated the contribution of TMEM106B polymorphisms in cohorts of FTD and FTD with amyotrophic lateral sclerosis patients from France and Italy. Patients carrying the C9orf72 expansion (n= 145) and patients with GRN mutations (n= 76) were compared with a group of FTD patients (n= 384) negative for mutations and to a group of healthy controls (n= 552). In our cohorts, the presence of the C9orf72 expansion did not correlate with TMEM106B genotypes but the association was very strong in individuals with pathogenic GRN mutations (p= 9.54× 10-6). Our data suggest that TMEM106B genotypes differ in FTD patient cohorts and strengthen the protective role of TMEM106B in GRN carriers. Further studies are needed to determine whether TMEM106B polymorphisms are associated with other genetic causes for FTD, including C9orf72 repeat expansions.

AB - TMEM106B was identified as a risk factor for frontotemporal lobar degeneration (FTD) with TAR DNA-binding protein 43kDa inclusions. It has been reported that variants in this gene are genetic modifiers of the disease and that this association is stronger in patients carrying a GRN mutation or a pathogenic expansion in chromosome 9 open reading frame 72 (C9orf72) gene. Here, we investigated the contribution of TMEM106B polymorphisms in cohorts of FTD and FTD with amyotrophic lateral sclerosis patients from France and Italy. Patients carrying the C9orf72 expansion (n= 145) and patients with GRN mutations (n= 76) were compared with a group of FTD patients (n= 384) negative for mutations and to a group of healthy controls (n= 552). In our cohorts, the presence of the C9orf72 expansion did not correlate with TMEM106B genotypes but the association was very strong in individuals with pathogenic GRN mutations (p= 9.54× 10-6). Our data suggest that TMEM106B genotypes differ in FTD patient cohorts and strengthen the protective role of TMEM106B in GRN carriers. Further studies are needed to determine whether TMEM106B polymorphisms are associated with other genetic causes for FTD, including C9orf72 repeat expansions.

KW - C9orf72

KW - FTD

KW - FTD-ALS

KW - GRN

KW - Rs1990622

KW - Rs3173615

KW - TMEM106B

UR - http://www.scopus.com/inward/record.url?scp=84922930035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922930035&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2014.06.023

DO - 10.1016/j.neurobiolaging.2014.06.023

M3 - Article

AN - SCOPUS:84922930035

VL - 35

SP - 2658.e1-2658.e5

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 11

ER -